{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:50:39Z","timestamp":1768387839031,"version":"3.49.0"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,5,23]]},"DOI":"10.18632\/oncotarget.16100","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T21:57:35Z","timestamp":1489183055000},"page":"34298-34309","source":"Crossref","is-referenced-by-count":20,"title":["Epha3 acts as proangiogenic factor in multiple myeloma"],"prefix":"10.18632","volume":"8","author":[{"given":"Antonella","family":"Caivano","sequence":"first","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco La","family":"Rocca","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Laurenzana","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Annese","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Histology and Embryology, University of Bari Medical School, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Tamma","sequence":"additional","affiliation":[{"name":"Department of Human Anatomy, Histology and Embryology, University of Bari Medical School, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Famigliari","sequence":"additional","affiliation":[{"name":"Division of Pathology, Department of Oncology, St Luigi Hospital, Turin, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Simeon","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Trino","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana De","family":"Luca","sequence":"additional","affiliation":[{"name":"Laboratory of Pre-clinical and Translational Research, Scientific Institute of Research and Cure (IRCCS), Referral Cancer Center of Basilicata (CROB), Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oreste","family":"Villani","sequence":"additional","affiliation":[{"name":"Department of Onco-Hematology, IRCCS-CROB, Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Berardi","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Basile","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Vacca","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Human Oncology, University of Bari Medical School, Bari, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Del","family":"Vecchio","sequence":"additional","affiliation":[{"name":"CEINGE-Biotecnologie Avanzate s.c.a r.l and Medical Biotechnologies, Federico II University, Naples, Italy"},{"name":"Department of Molecular Medicine and Medical Biotechnologies, Federico II University, Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pellegrino","family":"Musto","sequence":"additional","affiliation":[{"name":"Scientific Direction, IRCCS-CROB, Rionero in Vulture, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cilloni","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,10]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.beha.2007.08.002","article-title":"The malignant clone and the bone-marrow environment","volume":"20","author":"Anderson","year":"2007","journal-title":"Best Pract Res Clin Haematol"},{"key":"2","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064","article-title":"Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma","volume":"93","author":"Dammacco","year":"1999","journal-title":"Blood"},{"key":"3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/COC.0b013e3182a4676b","article-title":"Emerging therapies in multiple myeloma","volume":"38","author":"Tabbara","year":"2015","journal-title":"Am J Clin Oncol"},{"key":"4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nrd4175","article-title":"Therapeutic targeting of EPH receptors and their ligands","volume":"13","author":"Lackmann","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1050-1738(00)00046-3","article-title":"Eph receptors and ephrin ligands. essential mediators of vascular development","volume":"10","author":"Klein","year":"2000","journal-title":"Trends Cardiovasc Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1101\/gad.330105","article-title":"PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature","volume":"19","author":"Wilkinson","year":"2005","journal-title":"Genes Dev"},{"key":"7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nn0504-417","article-title":"Eph-ephrin promiscuity is now crystal clear","volume":"7","author":"Pasquale","year":"2004","journal-title":"Nat Neurosci"},{"key":"8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0074-7696(00)96005-4","article-title":"Eph receptors and ephrins: regulators of guidance and assembly","volume":"196","author":"Wilkinson","year":"2000","journal-title":"Int Rev Cytol"},{"key":"9","doi-asserted-by":"publisher","first-page":"a001768","DOI":"10.1101\/cshperspect.a001768","article-title":"Visual map development: bidirectional signaling, bifunctional guidance molecules, and competition","volume":"2","author":"O\u2019Leary","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1210\/en.2010-0232","article-title":"Role of EphA4 receptor signaling in thyroid development: regulation of folliculogenesis and propagation of the C-cell lineage","volume":"152","author":"Nilsson","year":"2011","journal-title":"Endocrinology"},{"key":"11","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1101\/gad.1973910","article-title":"Eph\/ephrin molecules\u2014a hub for signaling and endocytosis","volume":"24","author":"Adams","year":"2010","journal-title":"Genes Dev"},{"key":"12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1023\/B:JOMG.0000017433.83226.22","article-title":"Eph and ephrin signaling in mammary gland morphogenesis and cancer","volume":"8","author":"Ziemiecki","year":"2003","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"14","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/S0021-9258(19)50725-6","article-title":"Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line","volume":"267","author":"Busmanis","year":"1992","journal-title":"J Biol Chem"},{"key":"15","first-page":"4855","article-title":"Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules","volume":"60","author":"Coulie","year":"2000","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1242\/jcs.115.5.1059","article-title":"Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3-expressing 293T and melanoma cells by CrkII and Rho-mediated signalling","volume":"115","author":"Lackmann","year":"2002","journal-title":"J Cell Sci"},{"key":"17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00535-012-0549-4","article-title":"Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival","volume":"47","author":"Chen","year":"2012","journal-title":"J Gastroenterol"},{"key":"18","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1182\/blood.V94.7.2477.419k13_2477_2486","article-title":"Cloning and characterization of EphA3 (Hek) gene promoter: DNA methylation regulates expression in hematopoietic tumor cells","volume":"94","author":"Boyd","year":"1999","journal-title":"Blood"},{"key":"19","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1073\/pnas.89.5.1611","article-title":"Molecular cloning of HEK, the gene encoding a receptor tyrosine kinase expressed by human lymphoid tumor cell lines","volume":"89","author":"Boyd","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"20","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccr.2013.01.007","article-title":"EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme","volume":"23","author":"Ellacott","year":"2013","journal-title":"Cancer Cell"},{"key":"21","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1158\/0008-5472.CAN-14-0218","article-title":"Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment","volume":"74","author":"Garic","year":"2014","journal-title":"Cancer Res"},{"key":"22","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1158\/0008-5472.CAN-05-0758","article-title":"Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents","volume":"65","author":"Lackmann","year":"2005","journal-title":"Cancer Res"},{"key":"23","doi-asserted-by":"crossref","unstructured":"Lancet, Wei, Durrant. A phase I study of KB004, a novel non-fucosylated humaneered\u00ae antibody, targeted against the receptor tyrosine kinase EphA3, in advanced hematologic malignancies. 55th ASH Annual Meeting and Exposition. 2013. Abstract 3838.","DOI":"10.1182\/blood.V122.21.3838.3838"},{"key":"24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/leu.2013.350","article-title":"New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)","volume":"28","author":"Dimopoulos","year":"2014","journal-title":"Leukemia"},{"key":"25","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1634\/theoncologist.2014-0042","article-title":"European perspective on multiple myeloma treatment strategies in 2014","volume":"19","author":"Goldschmidt","year":"2014","journal-title":"Oncologist"},{"key":"26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S1097-2765(00)80342-1","article-title":"Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development","volume":"4","author":"Anderson","year":"1999","journal-title":"Mol Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.1038\/sj.onc.1204004","article-title":"The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization","volume":"19","author":"Pasquale","year":"2000","journal-title":"Oncogene"},{"key":"28","doi-asserted-by":"publisher","first-page":"re2","DOI":"10.1126\/stke.115re2","article-title":"Eph, a protein family coming of age: more confusion, insight, or complexity?","volume":"1","author":"Boyd","year":"2008","journal-title":"Sci Signal"},{"key":"29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1586\/ehm.12.19","article-title":"EPHA3 as a novel therapeutic target in the hematological malignancies","volume":"5","author":"Giles","year":"2012","journal-title":"Expert Rev Hematol"},{"key":"30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3109\/08977194.2014.982276","article-title":"EphA3 biology and cancer","volume":"32","author":"Vail","year":"2014","journal-title":"Growth Factors"},{"key":"31","doi-asserted-by":"publisher","first-page":"7011","DOI":"10.1038\/sj.onc.1205679","article-title":"Soluble Eph A receptors inhibit tumor angiogenesis and progression","volume":"21","author":"Chen","year":"2002","journal-title":"Oncogene"},{"key":"32","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1038\/bcj.2014.29","article-title":"The role of epigenetics in the biology of multiple myeloma","volume":"4","author":"Gr\u00f8nb\u00e6k","year":"2014","journal-title":"Blood Cancer J"},{"key":"33","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/sj.thj.6200351","article-title":"s-thalidomide has a greater effect on apoptosis than angiogenesis in a multiple myeloma cell line","volume":"5","author":"Malpas","year":"2004","journal-title":"Hematol J"},{"key":"34","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1182\/blood-2007-11-121681","article-title":"Elevated protein tyrosine phosphatase activity provokes Eph\/ephrin-facilitated adhesion of pre-B leukemia cells","volume":"112","author":"Lackmann","year":"2008","journal-title":"Blood"},{"key":"35","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1038\/onc.2011.412","article-title":"Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets","volume":"31","author":"Basile","year":"2012","journal-title":"Oncogene"},{"key":"36","doi-asserted-by":"publisher","first-page":"17965","DOI":"10.1073\/pnas.0705647104","article-title":"Interaction of endosialin\/TEM1 with extracellular matrix proteins mediates cell adhesion and migration","volume":"104","author":"Zhou","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"37","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.1994.tb08304.x","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"87","author":"Dammacco","year":"1994","journal-title":"Br J Haematol"},{"key":"38","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1161\/01.atv.0000102926.54780.e7","article-title":"JAM-1 regulation of endothelial cell migration: implications for angiogenesis","volume":"23","author":"Parise","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"H1917","DOI":"10.1152\/ajpheart.00983.2002","article-title":"Expression of genes involved in vascular development and angiogenesis in endothelial cells of adult lung","volume":"285","author":"McDonald","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"40","doi-asserted-by":"publisher","first-page":"9522","DOI":"10.1074\/jbc.M309326200","article-title":"Dissecting the EphA3\/Ephrin-A5 interactions using a novel functional mutagenesis screen","volume":"279","author":"Boyd","year":"2004","journal-title":"J Biol Chem"},{"key":"41","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1110\/ps.062665807","article-title":"Crystal structure of the human ephrin-A5 ectodomain","volume":"16","author":"Himanen","year":"2007","journal-title":"Protein Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1182\/blood-2003-04-1338","article-title":"Endothelial cells in the bone marrow of patients with multiple myeloma","volume":"102","author":"Petrucci","year":"2003","journal-title":"Blood"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T22:54:06Z","timestamp":1658789646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,10]]},"references-count":42,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2017,5,23]]}},"alternative-id":["16100","28415715"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16100","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,10]]}}}